Search Result "ocrelizumab"

Export

Research Article
Ocrelizumab Extended Interval Dosing in Primary Progressive MultipleSclerosis: An Italian Experience

Journal: Current Neuropharmacology

Volume: 22 Issue: 2 Year: 2024 Page: 339-345

Author(s): Maria Claudia Moretti

Advances in Therapies for Multiple Sclerosis

Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Volume: 1 Year: 2013

Author(s): Naila Makhani,Eluen A. Yeh

Doi: 10.2174/9781608057580113010004

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials

Volume: 5 Issue: 3 Year: 2010 Page: 179-188

Author(s): James J. Marriott, Paul W. OConnor

Immune Therapy of Multiple Sclerosis - Future Strategies

Journal: Current Pharmaceutical Design

Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497

Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl

Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects

Journal: Current Pharmaceutical Design

Volume: 18 Issue: 2 Year: 2012 Page: 209-219

Author(s): Martin S. Weber, Til Menge, Klaus Lehmann-Horn, Helena C. Kronsbein, Uwe Zettl, Johann Sellner, Bernhard Hemmer, Olaf Stuve

Review Article
Safety and Monitoring of the Treatment with Disease-Modifying Therapies(DMTs) for Multiple Sclerosis (MS)

Journal: Current Reviews in Clinical and Experimental Pharmacology

Volume: 18 Issue: 1 Year: 2023 Page: 39-50

Author(s):

Review Article
Current Understanding and Unknown Aspects of the Treatment of Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Opportunities for Future Studies

Journal: Current Rheumatology Reviews

Volume: 16 Issue: 4 Year: 2020 Page: 257-266

Author(s): Samira Alesaeidi,Mohammad Darvishi,Sasan Dabiri,Mojtaba GhasemiAdl,Arash Jafarieh,Soheil Tavakolpour

Review Article
Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials

Journal: Medicinal Chemistry

Volume: 14 Issue: 2 Year: 2018 Page: 144-154

Author(s): Ioannis Heliopoulos,Athanasia Patousi

General Review Article
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19Pandemic: A Critical Viewpoint

Journal: Current Neuropharmacology

Volume: 20 Issue: 1 Year: 2022 Page: 107-125

Author(s): Marco Salvetti,Ruggero Capra,Ferdinando Nicoletti,Chiara Calderoni,Antonietta Gentile,Gianmarco Bellucci,Marika Alborghetti

Research Article
Changes in John Cunningham Virus Index in Multiple Sclerosis PatientsTreated with Different Disease-Modifying Therapies

Journal: Current Neuropharmacology

Volume: 20 Issue: 10 Year: 2022 Page: 1978-1987

Author(s): Enrico Millefiorini,Salvatore Lo Fermo,Chiara Finocchiaro,Simona Toscano,Clara Grazia Chisari

Previous   Next

Go to   Results 1 - 1 of 63
Volume Years
Article Type
Publication Title
Subject Title
Content Type